Variant report

Variant	esv3358004
Chromosome Location	chr6:160940387-160942935
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:12)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:160918427..160920098-chr6:160939899..160941930,2	K562	blood:
2	chr6:160941041..160942817-chr6:161087432..161089515,2	K562	blood:
3	chr6:160940535..160941592-chr6:161088101..161089900,7	K562	blood:
4	chr6:160940997..160941666-chr6:160999443..161000039,2	K562	blood:
5	chr6:160940571..160941215-chr6:160954967..160955505,2	K562	blood:
6	chr6:160940621..160941316-chr6:161413631..161414342,2	MCF-7	breast:
7	chr6:160940670..160941542-chr6:161088487..161089076,2	MCF-7	breast:
8	chr6:160939583..160942817-chr6:161087432..161090286,3	K562	blood:
9	chr6:160475075..160476994-chr6:160939802..160942570,2	K562	blood:
10	chr6:160940613..160941580-chr6:160954987..160955524,2	MCF-7	breast:
11	chr6:160940089..160942020-chr6:161411986..161414301,2	MCF-7	breast:
12	chr6:160939489..160941375-chr6:160998330..161000013,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000272841	chromatin interactions
ENSG00000085511	chromatin interactions

Extended variants
information (count: 81 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:81 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536433278	chr6:160940403-160940404	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs546444482	chr6:160940444-160940445	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs576532104	chr6:160940460-160940461	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs73784265	chr6:160940475-160940476	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs538515627	chr6:160940476-160940477	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs370142731	chr6:160940528-160940529	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs73784266	chr6:160940590-160940591	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs73784267	chr6:160940594-160940595	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs537474634	chr6:160940637-160940638	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs139452017	chr6:160940730-160940731	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs574158220	chr6:160940741-160940742	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs12529098	chr6:160940792-160940793	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs532487143	chr6:160940881-160940882	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs545178236	chr6:160940902-160940903	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs560436258	chr6:160941070-160941071	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs111250047	chr6:160941109-160941110	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs73784268	chr6:160941131-160941132	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs546173191	chr6:160941135-160941136	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs563223880	chr6:160941163-160941164	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs531717209	chr6:160941232-160941233	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs6925865	chr6:160941253-160941254	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs7452889	chr6:160941265-160941266	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs527736380	chr6:160941292-160941293	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs77087137	chr6:160941309-160941310	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs368591349	chr6:160941315-160941316	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs527782389	chr6:160941338-160941339	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs35726251	chr6:160941344-160941345	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs73784269	chr6:160941349-160941350	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs568844059	chr6:160941385-160941386	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs116169511	chr6:160941394-160941395	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs554114402	chr6:160941407-160941408	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs574379485	chr6:160941434-160941435	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs547902644	chr6:160941474-160941475	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs553876280	chr6:160941484-160941485	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs190743669	chr6:160941514-160941515	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs147824938	chr6:160941533-160941534	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs183023835	chr6:160941539-160941540	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs556881412	chr6:160941555-160941556	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs576778191	chr6:160941590-160941591	Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs186796367	chr6:160941634-160941635	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs7452960	chr6:160941641-160941642	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs191636952	chr6:160941672-160941673	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs184226860	chr6:160941738-160941739	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs373926146	chr6:160941741-160941742	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs541162934	chr6:160941743-160941744	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs79691449	chr6:160941775-160941776	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs374719439	chr6:160941791-160941792	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs565087690	chr6:160941870-160941871	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs532190445	chr6:160941891-160941892	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs551916605	chr6:160942112-160942113	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Coronary artery disease	17160897	CNVD
Chordoma	18071362	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	17952125	CNVD
Coronary Disease	20032323	CNVD
Coronary Disease	20335594	CNVD
Breast cancer	22522925	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Recurrent pregnancy loss	19789632	CNVD

Chromatin state (count:329 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:160933600-160940400	Weak transcription	Liver	Liver
2	chr6:160934600-160941000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr6:160935200-160940600	Weak transcription	HepG2	liver
4	chr6:160935200-160941000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr6:160938600-160941000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr6:160938800-160940400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
7	chr6:160939200-160940600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
8	chr6:160939200-160940600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
9	chr6:160939400-160940600	Enhancers	Primary T helper cells fromperipheralblood	blood
10	chr6:160939600-160940800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr6:160939800-160940400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
12	chr6:160939800-160940400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
13	chr6:160940000-160940600	Enhancers	Primary T cells fromperipheralblood	blood
14	chr6:160940000-160940600	Enhancers	Primary T helper cells PMA-I stimulated	--
15	chr6:160940000-160940800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
16	chr6:160940200-160940400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr6:160940200-160940400	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr6:160940200-160940400	Enhancers	K562	blood
19	chr6:160940200-160940600	Enhancers	Primary T killer memory cells from peripheral blood	blood
20	chr6:160940200-160940600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr6:160940200-160940600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
22	chr6:160940200-160940800	Enhancers	Brain Anterior Caudate	brain
23	chr6:160940200-160940800	Enhancers	Fetal Muscle Trunk	muscle
24	chr6:160940200-160942000	Active TSS	A549	lung
25	chr6:160940400-160940600	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr6:160940400-160940600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
27	chr6:160940400-160940600	Enhancers	NHEK	skin
28	chr6:160940400-160940800	Bivalent Enhancer	Primary T cells from cord blood	blood
29	chr6:160940400-160940800	Active TSS	Primary hematopoietic stem cells short term culture	blood
30	chr6:160940400-160940800	Enhancers	Primary T helper naive cells from peripheral blood	blood
31	chr6:160940400-160940800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
32	chr6:160940400-160940800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
33	chr6:160940400-160940800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
34	chr6:160940400-160940800	Enhancers	Liver	Liver
35	chr6:160940400-160940800	Weak transcription	K562	blood
36	chr6:160940400-160941000	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
37	chr6:160940400-160941200	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
38	chr6:160940400-160941800	Active TSS	HUES48 Cell Line	embryonic stem cell
39	chr6:160940400-160941800	Active TSS	HUES64 Cell Line	embryonic stem cell
40	chr6:160940400-160941800	Active TSS	iPS-18 Cell Line	embryonic stem cell
41	chr6:160940400-160941800	Active TSS	iPS-20b Cell Line	embryonic stem cell
42	chr6:160940400-160941800	Active TSS	Skeletal Muscle Female	skeletal muscle
43	chr6:160940400-160942200	Active TSS	ES-I3 Cell Line	embryonic stem cell
44	chr6:160940400-160942200	Active TSS	Duodenum Mucosa	Duodenum
45	chr6:160940600-160940800	Enhancers	Primary hematopoietic stem cells	blood
46	chr6:160940600-160940800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr6:160940600-160940800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr6:160940600-160940800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr6:160940600-160940800	Enhancers	Adipose Nuclei	Adipose
50	chr6:160940600-160940800	Enhancers	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links